Biotricity (NASDAQ:BTCY) Trading Up 12.6% – What’s Next?

Biotricity, Inc. (NASDAQ:BTCY)’s share price traded up 12.6% during mid-day trading on Friday . The company traded as high as $0.52 and last traded at $0.45. 84,123 shares were traded during trading, an increase of 7% from the average session volume of 78,566 shares. The stock had previously closed at $0.40.

Biotricity Stock Performance

The company’s 50-day moving average price is $0.34 and its 200 day moving average price is $0.65. The stock has a market cap of $10.19 million, a PE ratio of -0.33 and a beta of 1.22.

Biotricity (NASDAQ:BTCY) last announced its earnings results on Monday, August 19th. The company reported ($0.49) EPS for the quarter. The business had revenue of $3.20 million for the quarter. On average, sell-side analysts anticipate that Biotricity, Inc. will post -0.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Biotricity

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC acquired a new position in Biotricity, Inc. (NASDAQ:BTCY) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity as of its most recent SEC filing. Hedge funds and other institutional investors own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.